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Aims Magnetic resonance (MR) imaging is widely used for diagnostic imaging inmedicine as it is considered a safe alternative to
ionizing radiation-based techniques. Recent reports on potential genotoxic effects of strong and fast switching electro-
magnetic gradients such as used in cardiac MR (CMR) have raised safety concerns. The aim of this study was to analyse
DNA double-strand breaks (DSBs) in human blood lymphocytes before and after CMR examination.
Methods
and results
In 20 prospectively enrolled patients, peripheral venous blood was drawn before and after 1.5 T CMR scanning. After
density gradient cell separation of blood samples,DNADSBs in lymphocyteswerequantified using immunofluorescence
microscopy and flow cytometric analysis.Wilcoxon signed-rank testing was used for statistical analysis. Immunofluores-
cence microscopic and flow cytometric analysis revealed a significant increase in median numbers of DNADSBs in lym-
phocytes induced by routine 1.5 T CMR examination.
Conclusion The present findings indicate that CMR should be used with caution and that similar restrictions may apply as for X-ray-
based andnuclear imaging techniques inorder to avoid unnecessarydamageofDNA integritywith potential carcinogenic
effect.
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Introduction
Magnetic resonance (MR) imaging is a widely used and well-
established non-invasive medical diagnostic imaging tool. By using a
static and a gradient magnetic field in combination with a radiofre-
quency field (RF), MR provides excellent contrast among different
tissues of the body including the brain, musculoskeletal system, and
the heart. Although long-term effects on human health from expos-
ure to strong static magnetic fields seem unlikely,1 acute effects such
as vertigo, nausea, change in blood pressure, reversible arrhythmia,2
and neurobehavioural effects have been documented from occupa-
tional exposition to 1.5 T.3 Cardiac MR (CMR) imaging requires
some of the strongest and fastest switching electromagnetic gradi-
ents available inMRexposing the patients to the highest administered
energy levels accepted by the controlling authorities.4 Studies focus-
ing on experimental teratogenic5–9 or carcinogenic10–12 effects
of MR revealed conflicting results. Since CMR is emerging as one
of the fastest growing new fields of broad MR application,13 it is of
particular concern that a recent in vitro study with CMR sequences
has reported on CMR-induced DNA damages in white blood
cells up to 24 h after exposure to 1.5 T CMR.4 It is in this context
that the European Parliament,14 the International Commission on
Non-Ionizing Radiation Protection (ICNIRP),15,16 and the World
Health Organization (WHO)17 have urgently called for an action
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in order to evaluate adverse biological effects of clinical MR
scanning.
The aim of the present study was to assess the impact of routine
CMR scanning on DNA double-strand breaks (DSBs) of peripheral
blood mononuclear cells (PBMCs) as a measure of the carcinogenic
potential of this examination.
Methods
Twenty consecutive patients referred for cardiac evaluation were
included. After obtaining written informed consent, 10 mL of periph-
eral blood was drawn before and after undergoing routine contrast
(gadobutrolum, Gadovist, Bayer Schering Pharma, Germany) enhanced
CMR examination18 on a 1.5 T MR scanner (Philips Achieva, Best, NL,
USA) as approved by the local ethics committee (KEK-Nr. 849).
PBMCs were obtained using density gradient separation (Histopaque
1077, Sigma-Aldrich) as previously established.19
The clinical CMR protocol used in our daily routine has been recently
reported in detail.20 In brief, a commercially availableMR scanner (Philips
1.5 T, Achieva, software release 3.2.1) equipped with a maximum
gradient strength of 42 mT/m and a maximum gradient speed of
180 mT/m/ms was used. The following standard pulse sequences to gen-
erate images were used: gradient echo, steady-state free precession,
FastSE, T2-weighted double-inversion black-blood spin-echo sequence
for oedema imaging, balanced SSFP sequence for perfusion and inversion
recovery segmented gradient echo sequence for late gadolinium
enhancement.
DSBs were detected by immunofluorescence microscopy using a
rabbit-anti-human phospho-histone g-H2AX and a goat-anti-rabbit-
AlexaFluor-488 antibody (CST Cell Signalling Technology, adapted
from May et al.21). Cell nuclei were counterstained with 4′ ,6-diamidino-
2-phenylindole (DAPI, Vector Laboratories) and the g-H2AX foci per
lymphocyte were visualized on an inverse confocal microscope
(CLSM-Model SP5, Leica Microsystems) and quantified by a blinded
observer.
With flow cytometry (FACScanto, BD Bioscience), DSBs were add-
itionally quantified in T-lymphocytes22,23 previously identified by a
mouse-anti-human CD3-APC antibody (Life Technologies). Based on
forward and side light scattering, PBMCs were gated for viable single-cell
events and proper compensation controls were used in flow cytometric
analyses to correct for spectral overlap.Data fromflowcytometric quan-
tification (MFI, geometric mean of fluorescence intensity of
g-H2AXpositive T-lymphocytes) was evaluated using FlowJo software
(V10.0.2, Tree Star, Inc.).
Based on a variation of g-H2AX assessment at 20% as reported by
Muslimovic et al.,22 an average difference in g-H2AX findings reported
in ex vivo experiments,4 aiming at alpha ¼ 0.05 and a power (12 b) of
0.8, the number of patients necessary was calculated between 10 and 15.
SPSS 20.0 (SPSS, Chicago, IL, USA) was used for all statistical analysis.
The Shapiro–Wilk test was applied to exclude normal distribution of
data sets. This was followed by testing for significant differences
betweenDSBs before and afterCMRexamination by using theWilcoxon
signed-rank test. P-values of ,0.05 (two-tailed) were considered statis-
tically significant.
Results
Mean age of patients was 53+ 13 years and 16 (80%) were males.
Ten patients were referred for evaluation of cardiomyopathy and
10 for the assessment of myocardial ischaemia. The mean CMR
scan duration was 68+22 min with an average contrast media
bolus of 15+ 4 mL. The patient baseline characteristics are given
in Table 1.
By immunofluorescence microscopy (Figure 1), the median
number of DSBs (foci, Table 2) per lymphocyte in baseline samples
was 0.066 (range: 0–0.661) and increased significantly (P, 0.05)
after CMR exposure to 0.190 (range: 0–1.065, Figure 2).
In T-lymphocytes, flowcytometry (Figure 3) revealed amedianMFI
(arbitrary units) of 2758 (range: 1907–5109) before and3232 (range:
2413–5484) after CMR (P, 0.005, Table 2 and Figure 4).
Discussion
We show here that clinical routine CMR scanning exerts genotoxic
effects. Although many experimental in vitro studies have suggested
DNA damage after exposure to MR imaging, we present the first
in vivo results documenting that contrastCMRscanning indaily clinical
routine is associated with increased lymphocyte DNA damage.
The different components of the magnetic field during CMR may
have contributed to the observed DNA damage. The gradient field
generated during MR scanning includes extremely low frequencies
(ELF), which have been classified by the International Agency for Re-
searchonCancer (IARC) as possible human carcinogen (group2B)24
based on a large body of literature on the genotoxic effects of ELF
magnetic fields.25–28 The latter seem to be involved directly and in-
directly in DNA and chromosomal damage by inducing reactive
oxygen species.29 Similarly, DNA damage and chromosome altera-
tions have been discussed after exposure to RF.
Our results do not allow commenting on the persistence of the
induced DNA damage, although this is a key issue of genetic risk as-
sessment, because damage can trigger DNA instability and exert
tumourigenic effects.Due to the long timedelaybetweenDSB induc-
tion and resulting cancer development, our study cannot quantify
such long-term effects as this was beyond the scope of the present
study. This, however, is true in principle for any observation of DSB
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Table 1 Patient baseline characteristics (n 5 20)
Age (years+ SD) 53+13
BMI (kg/m2+ SD) 25+4
Male, n (%) 16 (80)
Cardiovascular risk factors, n (%)
Arterial hypertension 6 (30)
Diabetes mellitus 4 (20)
Dyslipidaemia 4 (20)
Smoking 2 (10)
Positive family history 1 (5)
Medications, n (%)
Aspirin 7 (35)
Beta-blocker 9 (45)
ACE/angiotensin II inhibitor 8 (40)
Statin 7 (35)
SD, standard deviation; BMI, body mass index.
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Figure 1 Visualization of double-strand breaks (DSBs) in nuclei (arrow heads) of human lymphocytes of two patients before and after cardiac
magnetic resonance scans by immunofluorescence microscopy. DSBs (foci, white arrows) are detected by g-H2AX staining (green).
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induction from any diagnostic radiation exposure including ionizing
radiation, for which no direct observational proof of its adverse
impact on outcome is available due to the small scale of damage
and the long delay between exposure and event. In view of the
growinguseof newgenerationMRscannerswith increasingmagnetic
field strength (higher Tesla), our results seem to support the sugges-
tions of the ICNIRP for anurgent needofmonitoringworkers and for
epidemiologic studieson subjectswith high levels of exposureor par-
ticular conditions such as for example pregnant occupational
workers.30
Despite activation of repair mechanisms, persistence of DNA
damage has been found in human lymphocytes more than 24 h
after exposing patients and blood samples to CMR scanning.4
Co-genotoxic effects of MR in combination with the administered
gadolinium-based contrast material may further have contributed
to DNA damage due to the potentiating effect of gadolinium-based
contrast material and MR exposure.31 As in our study all patients
underwent contrast enhanced CMR, reflecting widely used clinical
practice,32 we cannot differentiate the precise contribution of the
known genotoxic effect of the gadolinium-based contrast material
from the effects of the magnetic field. However, the use of contrast
material is generally an integrated part of CMR scanning and there-
fore our results may appropriately represent the effect of a routine
CMR scan. The absolute amount of DNA damage is certainly larger
in our study compared with previous in vitro studies, as the entire
blood of each patient rather than a blood sample was exposed
during CMR. According to the assumptions used in the field of radi-
ation protection, an increased number of DNAdamages confer a lin-
early increased risk of cancer. Conversely, even a low number of
DSBs may represent a carcinogenic risk according to the linear-no
threshold theory. Our results compare well to the more than
two-fold increase inDSBs induced byCMRand assessed by immuno-
fluorescence microscopy as reported by Simi et al.,4 which was sub-
stantially less pronounced than the almost six-fold increase observed
after cardiacCTbyKuefner et al.33 Although only a fewdata are avail-
able using FACS analyses for this low scale of signal, the excellent
agreement between microscopy and FACS over a large range of
signal including the present study strengthens the validity of our
results.34
Of note, observations in several subsets of patients seem to
suggest increased sensibilities to MRI exposition, as higher suscepti-
bility forDNAdamagebyMRI hasbeen found forexample in lympho-
cytes of patients with Turner’s syndrome.35 Thus, inappropriate
examinations should be avoided and CMR should be used with
caution and similar restrictions may apply as for X-ray-based and
nuclear imaging techniques where the potential harm is carefully
weighted against the obvious benefit offered by each examination
in order to avoid unnecessary damage of DNA integrity with poten-
tial carcinogenic effect.
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Table 2 Increase in double-strand breaks after cardiac
magnetic resonance assessed by immunofluorescence
Microscopy foci per
lymphocyte
Flow cytometry
MFI
Before After Before After
Mean 0.143 0.270* 2989 3395*
SD 0.191 0.227 850 906
Median 0.066 0.190* 2758 3232*
MAD 0.137 0.199 640 696
IQR 0.169 0.257 1133 1198
IF, immunofluorescence (units are foci per lymphocyte); MFI, geometric mean of
T-lymphocyte fluorescence intensity (arbitrary units); g-H2AX, marker of DSBs;
SD, standard deviation; MAD, median absolute deviation; IQR, interquartile range.
*Indicates P, 0.05 vs. before.
Figure 2 Amount of double-strand breaks before and after cardiac magnetic resonance (CMR) scan by immunofluorescence microscopy. After
CMR scanning, there was a significant increase (*P, 0.05) in g-H2AX foci per lymphocyte by immunofluorescence microscopy. Bars indicate
median values with median absolute deviation (left panel) and individual values are interconnected with a line (right panel).
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Figure3 Flowcytometric analysisof double-strandbreaks (g-H2AXpositiveT-lymphocytes) beforeandaftercardiacmagnetic resonance (CMR)
scan. T-lymphocytes were readily identified by representative dot plots and histograms (lymphocytes, DAPI, and CD3). The shift of the left curve
(red, before CMR) to the right curve (blue, after CMR) in the presented overlay indicates an increase in double-strand breaks (g-H2AXpositive
T-lymphocytes). SSC-A: side scatter channel area. FSC-A: forward scatter channel area. DAPI: 4′,6-diamidino-2-phenylindole, counterstaining
cell nuclei. CD3: mouse-anti-human CD3-APC antibody counterstaining specifically the T-lymphocytes.
Figure 4 Amount of double-strand breaks before and after cardiac magnetic resonance scan by flow cytometry of g-H2AXpositive
T-lymphocytes using geometricmeanfluorescence intensity (MFI). ThemedianMFI increased significantly aftercardiacmagnetic resonance scanning
(*P, 0.005, left panel). Individual values are interconnected with a line (right panel).
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